- Home
- NPCE vs FINS Comparison
NPCE vs FINS Comparison
Compare NPCE & FINS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NPCE | FINS |
|---|---|---|
| Founded | 1997 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 514.3M | 436.4M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | NPCE | FINS |
|---|---|---|
| Price | $17.32 | $13.19 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | ★ 224.5K | 78.0K |
| Earning Date | 11-04-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.97% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $94,864,000.00 | N/A |
| Revenue This Year | $24.82 | N/A |
| Revenue Next Year | $0.77 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 24.08 | N/A |
| 52 Week Low | $7.56 | $11.61 |
| 52 Week High | $18.98 | $12.57 |
Technical Indicators
Market Signals| Indicator | NPCE | FINS |
|---|---|---|
| Relative Strength Index (RSI) | 66.91 | 55.29 |
| Support Level | $15.03 | $13.15 |
| Resistance Level | $16.33 | $13.30 |
| Average True Range (ATR) | 0.69 | 0.13 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 89.43 | 79.49 |
Price Performance
Historical ComparisonAbout NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.
About FINS Angel Oak Financial Strategies Income Term Trust of Beneficial Interest
Angel Oak Financial Strats Income Term is a non-diversified, closed-end management investment company. The fund's objective is to seek current income with a secondary objective of total return. In pursuing its investment objective, the fund invests mainly in debt issued by financial institutions, including subordinated debt, unrated debt, senior debt, and high-yield securities.